Non-Surgical NAD+ Therapy in Columbia, SC

Recovery timelines vary based on condition severity, patient health profile, and the specific nad+ protocol selected. Most Columbia patients begin noticing changes within 2-6 weeks, with deeper tissue remodeling continuing over the following 3-6 months. Unlike surgery, there is no hospital stay, no general anesthesia, and no extended rehabilitation program — you return to your normal schedule the same day.

Not every patient is a candidate for nad+ therapy, and our team won't recommend it for patients who aren't. The consultation process is designed to identify who will benefit most — and to route those who won't toward more appropriate care. Honest candidacy assessment is how we protect our patients and maintain our outcomes record in Columbia and across the Columbia Metro area.

NAD+ Therapy is not a single product — it's a category of intervention that includes a range of biological materials, each with distinct mechanisms and applications. At Regenerative Revival, our clinicians work with physicians to select the protocol that best matches your condition, your labs, and your goals. Columbia patients receive a personalized plan, not a one-size-fits-all injection.

Access to cutting-edge regenerative care has historically been a function of geography — concentrated in major medical centers and available only to those who could travel and pay cash. Regenerative Revival changes this by operating a fully mobile, concierge model: our clinicians come to Columbia residents, eliminating the access barrier entirely. The same protocols available in elite clinics are now available in your home.

The consent process for nad+ therapy at Regenerative Revival is designed to ensure Columbia patients make fully informed decisions. We explain the mechanism of action, the realistic range of outcomes based on published literature and our own patient data, the known risks, and the alternatives to treatment. We don't present nad+ as the only option — we present it as one option in a considered clinical context. Patients who proceed do so because the evidence and their own values align with the approach.

Long-term outcomes from nad+ therapy depend significantly on patient compliance with post-treatment protocols and lifestyle factors that support tissue health. Columbia patients who maintain adequate hydration, follow the recommended activity progression, and attend their follow-up assessments consistently report better 12-month outcomes than those who do not. Our clinical team provides detailed post-treatment guidance and a direct line for any questions that arise during recovery.

Some Columbia patients ask whether nad+ therapy is a permanent solution or a treatment they'll need to repeat. In most cases, a single protocol produces lasting structural improvement — not indefinite relief requiring maintenance dosing. However, patients with ongoing degenerative conditions or high-activity lifestyles may benefit from a follow-up treatment at 12-24 months to address any progression. This is evaluated on a case-by-case basis, not sold as a subscription.